Beta Bionics (BBNX) Treasury Shares (2025 - 2026)

Beta Bionics' (BBNX) quarterly Treasury Shares came in at $2.4 million in Q1 2026, up 157.23% year-on-year from $937063.0 in Q1 2025, and up 219.73% quarter-over-quarter from $753885.0 in Q4 2025.

Beta Bionics (BBNX) Treasury Shares (2025 - 2026) Analysis & Trends

Beta Bionics has disclosed Treasury Shares across 2 years of filings, most recently posting $2.4 million for Q1 2026.

  • Treasury Shares for Q1 2026 came in at $2.4 million, up 157.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 157.23% YoY), and the FY2025 annual result was $753885.0, changed N/A from the prior year.
  • Treasury Shares came in at $2.4 million for Q1 2026 at Beta Bionics, up from $753885.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.4 million in Q1 2026 to a low of $753885.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 256.42 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 83.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 26.40 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 4.51 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 900,000.00
10 Beta Bionics 617.66 Mn 587.36 Mn 16.44 Mn 2.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.41 Mn
Mar 31, 2026 2.41 Mn
Dec 31, 2025 753,885.00
Dec 31, 2025 753,885.00
Sep 30, 2025 824,771.00
Sep 30, 2025 824,771.00
Jun 30, 2025 887,963.00
Jun 30, 2025 887,963.00
Mar 31, 2025 937,063.00
Mar 31, 2025 937,063.00